Cystic Fibrosis Management and Care Quiz

Cystic Fibrosis primarily affects the lungs, leading to respiratory complications.

Hypertonic saline helps promote mucus clearance in the airways of individuals with Cystic Fibrosis.

Chest physiotherapy helps enhance mucus clearance from the airways, reducing the risk of infections and improving lung function.

Newborn screening for Cystic Fibrosis is significant as it allows for early diagnosis and intervention, improving outcomes for affected individuals.

Albuterol is commonly used as a bronchodilator in Cystic Fibrosis management to help improve airflow in the lungs.

Cystic Fibrosis is primarily caused by a genetic mutation affecting the CFTR gene.

Persistent coughing is a common symptom of Cystic Fibrosis, often due to mucus buildup in the airways.

The most common genetic mutation associated with Cystic Fibrosis is Delta F508.

Pneumonia is a common respiratory complication in Cystic Fibrosis patients due to chronic lung infections.

Male infertility is a common complication of Cystic Fibrosis, often due to obstructed vas deferens.

Airway clearance techniques aim to improve lung function by removing mucus and reducing the risk of infections.

Individuals with Cystic Fibrosis often have impaired absorption of fat-soluble vitamins, including Vitamin D.

Pancreatic enzyme replacement therapy helps individuals with Cystic Fibrosis digest food properly by replacing enzymes that are lacking.

Cystic Fibrosis-related diabetes can lead to complications such as cardiovascular disease.

CFTR modulators work by enhancing chloride transport across cell membranes, addressing the underlying defect in Cystic Fibrosis.